Roche’s schizophrenia drug fails in two late-stage trials

January 21, 2014 7:47 AM

17 0

ZURICH: Swiss drugmaker Roche said on Tuesday its experimental schizophrenia drug failed to significantly reduce the "negative symptoms" of the disorder in two-late stage studies.

Results of two Phase III trials found adding bitopertin to antipsychotic therapy did not significantly reduce the negative symptoms compared with placebo. A third late-stage study is ongoing.

Read more

To category page